Literature DB >> 3545497

The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway.

D Broek, T Toda, T Michaeli, L Levin, C Birchmeier, M Zoller, S Powers, M Wigler.   

Abstract

The gene corresponding to the S. cerevisiae cell division cycle mutant cdc25 has been cloned and sequenced, revealing an open reading frame encoding a protein of 1589 amino acids that contains no significant homologies with other known proteins. Cells lacking CDC25 have low levels of cyclic AMP and decreased levels of Mg2+-dependent adenylate cyclase activity. The lethality resulting from disruption of the CDC25 gene can be suppressed by the presence of the activated RAS2val19 gene, but not by high copy plasmids expressing a normal RAS2 or RAS1 gene. These results suggest that normal RAS is dependent on CDC25 function. Furthermore, mutationally activated alleles of CDC25 are capable of inducing a set of phenotypes similar to those observed in strains containing a genetically activated RAS/adenylate cyclase pathway, suggesting that CDC25 encodes a regulatory protein. We propose that CDC25 regulates adenylate cyclase by regulating the guanine nucleotide bound to RAS proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545497     DOI: 10.1016/0092-8674(87)90076-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  164 in total

1.  Isolation and characterization of temperature-sensitive mutations in the RAS2 and CYR1 genes of Saccharomyces cerevisiae.

Authors:  H Mitsuzawa; I Uno; T Oshima; T Ishikawa
Journal:  Genetics       Date:  1989-12       Impact factor: 4.562

Review 2.  Signal control through Raf: in sickness and in health.

Authors:  Jihan K Osborne; Elma Zaganjor; Melanie H Cobb
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 3.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.

Authors:  D W Stacey; L A Feig; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites.

Authors:  A Valencia; M Kjeldgaard; E F Pai; C Sander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Identification of a nucleotide exchange-promoting activity for p21ras.

Authors:  J Downward; R Riehl; L Wu; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 7.  Transcriptional regulation in yeast during diauxic shift and stationary phase.

Authors:  Luciano Galdieri; Swati Mehrotra; Sean Yu; Ales Vancura
Journal:  OMICS       Date:  2010-09-23

8.  MSI1, a negative regulator of the RAS-cAMP pathway in Saccharomyces cerevisiae.

Authors:  R Ruggieri; K Tanaka; M Nakafuku; Y Kaziro; A Toh-e; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  The GTS1 gene, which contains a Gly-Thr repeat, affects the timing of budding and cell size of the yeast Saccharomyces cerevisiae.

Authors:  K Mitsui; S Yaguchi; K Tsurugi
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Ras membrane targeting is essential for glucose signaling but not for viability in yeast.

Authors:  S Bhattacharya; L Chen; J R Broach; S Powers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.